Article Details
Retrieved on: 2025-01-09 18:13:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In November, the FDA approved the Varipulse Platform for drug-refractory paroxysmal Atrial Fibrillation (AFib). Also Read: Your Healthcare Costs ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here